Share Name Share Symbol Market Type Share ISIN Share Description
Futuragene Plc LSE:FGN London Ordinary Share GB0031791782 ORD 0.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 89.00p 0.00p 0.00p - - - 0 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Alternative Energy 0.2 -2.2 -4.7 - 50.04

Futuragene (FGN) Latest News

Real-Time news about Futuragene (London Stock Exchange): 0 recent articles
More Futuragene News
Futuragene Takeover Rumours

Futuragene (FGN) Share Charts

1 Year Futuragene Chart

1 Year Futuragene Chart

1 Month Futuragene Chart

1 Month Futuragene Chart

Intraday Futuragene Chart

Intraday Futuragene Chart

Futuragene (FGN) Discussions and Chat

Futuragene (FGN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Futuragene trades in real-time

Futuragene (FGN) Top Chat Posts

DateSubject
29/9/2016
09:20
Futuragene Daily Update: Futuragene Plc is listed in the Alternative Energy sector of the London Stock Exchange with ticker FGN. The last closing price for Futuragene was 89p.
Futuragene Plc has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 56,222,239 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Futuragene Plc is £50,037,792.71.
13/4/2010
18:12
kooba: agree n_w_b could even be a few shorts closing as well,either way takeover talks ongoing at equivalent of then current share price which was 88p high 82p low on day of rns 23rd feb.todays price action perhaps indicating progress is being made, did hear mention that predator could be brazilian fwiw.
13/4/2010
14:53
someuwin: Worth repeating - Evolutions initial coverage of FGN from last october. (Bear in mind that since October we have had news on... poplar trees. Cotton plants with Bayer. Chinese patent for food and non food drought tolerance. Japanese patent for cell wall modification. Chinese licensing agreement for Cotton...) FuturaGene (FGN.L) Buy Trade of the decade Relentless population growth is placing a severe strain on our agricultural resources. By 2020 the world's forests and farms will have to provide timber and food for 800m more people than they do today. The drive to boost crop yields led to a twenty-fold increase in Monsanto's share price in the last decade; we think similar trends will make FuturaGene a stellar performer in the next. Yield-enhancing technology for the forestry and biofuel sectors FuturaGene's genetic technology can boost farm and forestry crop yields by 25-300%, depending on species. It can also accelerate growth, improve stress tolerance and enhance productivity in paper and biofuel processing plants. Billion-dollar customers in billion-dollar markets The Top 10 wood-producing countries exported $100bn of forestry products in 2005, so a 25% yield increase would create more than $25bn of value a year. Unsurprisingly, several major forestry and agricultural players have expressed interest in FuturaGene's technology. Suzano Papel e Celulose (EV $5bn), the world's No2 eucalyptus pulp producer, has contracted to use FuturaGene's technology in its plantations. Suzano has completed a successful three-year trial of FuturaGene's eucalyptus prototypes, and is currently pursuing regulatory approval for commercial deployment. FuturaGene is also working with: the largest supplier of alfalfa seeds in the US; a leading developer and supplier of seedlings for China's forestry industry; a biotech with access to the huge US corn market; one of Thailand's largest forestry companies. If these partnerships progress to plan, we estimate they could generate annual royalties worth tens of millions of dollars. A hidden gem with huge potential Although FuturaGene has made excellent progress with customers in recent years, a legal dispute – now fully resolved – with the company's founders prevented the current management from promoting the story to investors. We now expect a more active approach to investor relations and positive newsflow from the Suzano partnerships – and a significant boost to FuturaGene's profile. Demographic trends suggest that the next decade will be extremely interesting for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology could add billions of dollars to the annual output of the forestry and biofuel industries. Even if FuturaGene captured only a tiny proportion of that value, its profits would dwarf the company's current market cap of £25m. BUY. http://www.futuragene.com/pdf/Research_Note_FGN_05-10-09.pdf
25/3/2010
13:56
kooba: if they came out with a bid off now after the share price movement and volume would expect the board to be arrested let alone some of their shareholders!!
25/3/2010
11:41
mf10: He only raised his holding on the 16th and gained nothing in terms of share price movement. Even if the bid was 85p, it's a small profit. Doubt the investor has anything to do with the deal talks or the company. And of course, they're all claiming innocence! Let's face it, people invest based on market rumours every other day and then the company puts out a statement to say that market speculation was correct. Do they all get investigated for insider dealing? Let's just say that it's not that easy to keep someone talking when talks are ongoing about possible deals and the FSA will have a very hard time proving anything having spent years and thousands of man hours to arrest 7 people!!
02/3/2010
14:38
someuwin: Normally, if the target company feels that an approach is too low they will indicate as much in the RNS i.e say that an approach has been made which the board feels does not adequately value blah blah blah. I see nothing in the share price movement RNS to suggest that they are unhappy with the approach and they admit that discussions are underway. No doubt the management would be handsomely rewarded, would be kept on to progress the work and would be happier being ownwd by Bayer or Monsanto rather than retail investors. The only ones who really lose out are us PIs who believed in the long term growth story. I may be wrong of course and they may spurn the bidder (or a secondary bid might appear) but I've locked in profit at this level and will watch from the sidelines for now.
02/3/2010
14:11
n_w_b: Not sure I agree, they had an approach with an initial offer of approximately the share price, when it wasn 10% higher. Surely thery're not going to accept even that, with their potential and not needed cash until 2012 when revenue will be coming in. .
24/2/2010
09:05
n_w_b: Agree...Just because a company gets a bid at a certain price, doesn't mean they're going to accept it. What it does do though is provide a floor for the share price. It's got to be at least a premium to current Broker price targets. EVO's 100p target from October, which is before the deals that have been done recently, should be raised and say 20% extra as a starting point, for anyone to take a bid seriously. I'm gutted, as I was in for the long term and wanted to benefit when all the revenue streams started coming in. Unfortunately all too often companies with massive potential and gobbled up by majors, before there allowed to become competitors. However...it looks like our fate is going that way and as such I'd consider 130p if it were offered today.
23/2/2010
22:15
n_w_b: Tomorrows FT "Futragene, a biotechnology company that specialises in plant cell modification, eased 2.4 per cent to 82p on news of an indicative offer approach, pitched at close to the current share price. However, traders reckon a bid battle could break out, with Bayer, a licensee, and Monsanto both likely to be interested." Link
23/2/2010
10:58
someuwin: For those that haven't seen it this is the introduction to Evolutions initial coverage of FGN last october. (Bear in mind that since October we have had news on... poplar trees. Cotton plants with Bayer. Chinese patent for food and non food drought tolerance. Japanese patent for cell wall modification. Chinese licensing agreement for Cotton...) FuturaGene (FGN.L) Buy Trade of the decade Relentless population growth is placing a severe strain on our agricultural resources. By 2020 the world's forests and farms will have to provide timber and food for 800m more people than they do today. The drive to boost crop yields led to a twenty-fold increase in Monsanto's share price in the last decade; we think similar trends will make FuturaGene a stellar performer in the next. Yield-enhancing technology for the forestry and biofuel sectors FuturaGene's genetic technology can boost farm and forestry crop yields by 25-300%, depending on species. It can also accelerate growth, improve stress tolerance and enhance productivity in paper and biofuel processing plants. Billion-dollar customers in billion-dollar markets The Top 10 wood-producing countries exported $100bn of forestry products in 2005, so a 25% yield increase would create more than $25bn of value a year. Unsurprisingly, several major forestry and agricultural players have expressed interest in FuturaGene's technology. Suzano Papel e Celulose (EV $5bn), the world's No2 eucalyptus pulp producer, has contracted to use FuturaGene's technology in its plantations. Suzano has completed a successful three-year trial of FuturaGene's eucalyptus prototypes, and is currently pursuing regulatory approval for commercial deployment. FuturaGene is also working with: the largest supplier of alfalfa seeds in the US; a leading developer and supplier of seedlings for China's forestry industry; a biotech with access to the huge US corn market; one of Thailand's largest forestry companies. If these partnerships progress to plan, we estimate they could generate annual royalties worth tens of millions of dollars. A hidden gem with huge potential Although FuturaGene has made excellent progress with customers in recent years, a legal dispute – now fully resolved – with the company's founders prevented the current management from promoting the story to investors. We now expect a more active approach to investor relations and positive newsflow from the Suzano partnerships – and a significant boost to FuturaGene's profile. Demographic trends suggest that the next decade will be extremely interesting for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology could add billions of dollars to the annual output of the forestry and biofuel industries. Even if FuturaGene captured only a tiny proportion of that value, its profits would dwarf the company's current market cap of £25m. BUY.
03/1/2010
10:05
n_w_b: As well as bulking them out by 10%, Evolution securities say they can grow faster; giving a 25-300% yield gain. http://www.futuragene.com/pdf/Research_Note_FGN_05-10-09.pdf Trade of the decade Relentless population growth is placing a severe strain on our agricultural resources. By 2020 the world's forests and farms will have to provide timber and food for 800m more people than they do today. The drive to boost crop yields led to a twenty-fold increase in Monsanto's share price in the last decade; we think similar trends will make FuturaGene a stellar performer in the next. Yield-enhancing technology for the forestry and biofuel sectors FuturaGene's genetic technology can boost farm and forestry crop yields by 25-300%, depending on species. It can also accelerate growth, improve stress tolerance and enhance productivity in paper and biofuel processing plants. Billion-dollar customers in billion-dollar markets The Top 10 wood-producing countries exported $100bn of forestry products in 2005, so a 25% yield increase would create more than $25bn of value a year. Unsurprisingly, several major forestry and agricultural players have expressed interest in FuturaGene's technology. Suzano Papel e Celulose (EV $5bn), the world's No2 eucalyptus pulp producer, has contracted to use FuturaGene's technology in its plantations. Suzano has completed a successful three-year trial of FuturaGene's eucalyptus prototypes, and is currently pursuing regulatory approval for commercial deployment. FuturaGene is also working with: the largest supplier of alfalfa seeds in the US; a leading developer and supplier of seedlings for China's forestry industry; a biotech with access to the huge US corn market; one of Thailand's largest forestry companies. If these partnerships progress to plan, we estimate they could generate annual royalties worth tens of millions of dollars. A hidden gem with huge potential Although FuturaGene has made excellent progress with customers in recent years, a legal dispute – now fully resolved – with the company's founders prevented the current management from promoting the story to investors. We now expect a more active approach to investor relations and positive newsflow from the Suzano partnerships – and a significant boost to FuturaGene's profile. Demographic trends suggest that the next decade will be extremely interesting for FuturaGene and its shareholders. Wide adoption of FuturaGene's technology could add billions of dollars to the annual output of the forestry and biofuel industries. Even if FuturaGene captured only a tiny proportion of that value, its profits would dwarf the company's current market cap of £25m. BUY.
Futuragene share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20160929 11:53:39